Back to results
US 10,519,134 B2Granted
Pyrazole compounds and methods of making and using same
AssigneeLundbeck La Jolla Research Center, Inc.
InventorsOlivia D. Weber, Michael B. Shaghafi, Cheryl A. Grice, Todd K. Jones
Life of this patent
Estimating the term…
Abstract
Provided herein are pyrazole compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of, for example, pain.
Claims20
A compound of Formula (III):
- wherein:
- R1 is —N(R2)C(O)R15 or —N(H)SO2R15;
- R2 is H or C1-6alkyl;
- R3 is H or optionally substituted phenyl;
- R4 is H, halogen, —OR′, C1-6alkyl, C2-6alkynyl, C1-6haloalkyl, C3-6cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted C1-6alkyl-heterocycloalkyl, optionally substituted phenyl, optionally substituted heteroaryl, —CO2H, or —C(O)NR8R9;
- R5 is H, halogen, —CN, C1-6alkyl, C1-6haloalkyl, or phenyl;
- or
- R4 and R5 are combined to form an optionally substituted heterocycloalkyl ring or an optionally substituted heteroaryl ring;
- R6 is H, halogen or C1-6alkyl;
- R7 is H, C1-6 alkyl, optionally substituted phenyl, optionally substituted C1-6 alkyl-phenyl, optionally substituted heteroaryl, optionally substituted heterocycloalkyl, or —C1-6alkylC(O)NR10R11;
- R8 and R9 are each independently H, or C1-6alkyl;
- or R8 and R9 together with the nitrogen to which they are attached are combined to form an optionally substituted heterocycloalkyl ring;
- R10 and R11 are each independently H, or C1-6alkyl;
- or R10 and R11 together with the nitrogen to which they are attached are combined to form a heterocycloalkyl ring;
- and
- R15 is optionally substituted C1-6alkyl;
- or a solvate, hydrate, tautomer, N-oxide, or pharmaceutically acceptable salt thereof.
14 more elements
A compound of Formula (IV):
- wherein:
- R1 is —N(R2)C(O)R15 or —N(H)SO2R15;
- R2 is H or C1-6alkyl;
- R3 is H or optionally substituted phenyl;
- R4 is H, halogen, —OR7, C1-6alkyl, C2-6alkynyl, C1-6haloalkyl, C3-6cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted C1-6alkyl-heterocycloalkyl, optionally substituted phenyl, optionally substituted heteroaryl, —CO2H, or —C(O)NR8R9;
- R5 is H, halogen, —CN, C1-6alkyl, C1-6haloalkyl, or phenyl;
- or
- R4 and R5 are combined to form an optionally substituted heterocycloalkyl ring or an optionally substituted heteroaryl ring;
- R6 is H, halogen or C1-6alkyl;
- R7 is H, C1-6 alkyl, optionally substituted phenyl, optionally substituted C1-6 alkyl-phenyl, optionally substituted heteroaryl, optionally substituted heterocycloalkyl, or —C1-6alkylC(O)NR10R11;
- R8 and R9 are each independently H, or C1-6alkyl;
- or R8 and R9 together with the nitrogen to which they are attached are combined to form an optionally substituted heterocycloalkyl ring;
- R10 and R11 are each independently H, or C1-6alkyl;
- or R10 and R11 together with the nitrogen to which they are attached are combined to form a heterocycloalkyl ring;
- R12 is H or C1-6alkyl;
- R13 is H or C1-6alkyl;
- and
- R15 is optionally substituted C1-6alkyl;
- or a solvate, hydrate, tautomer, N-oxide, stereoisomer, or pharmaceutically acceptable salt thereof.
16 more elements
A compound selected from:
- or a solvate, hydrate, tautomer, N-oxide, or pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.